| Aktie | Ticker | Breite | GCS | 2026/Q1 | 2025/Q4 | 2025/Q3 | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Investment ($) | QoQ ($) | QoQ (%) | Anz. Fonds | Investment ($) | QoQ ($) | QoQ (%) | Anz. Fonds | Investment ($) | QoQ ($) | QoQ (%) | Anz. Fonds | ||||
| 351.507.330 $ | -155.274.923 $ | -30,9 % | 7 | 506.782.253 $ | +179.258.135 $ | +51,9 % | 7 | 327.524.118 $ | +150.988.764 $ | +72,9 % | 7 | ||||
| Zenas BioPharma, Inc. | ZBIO | → 0 | Schwach | 76.619.558 $ | -65.685.105 $ | -46,2 % | 1 | 142.304.663 $ | +58.802.493 $ | +70,4 % | 1 | 83.502.170 $ | +47.054.601 $ | +129,1 % | 1 |
| Immunome Inc. | IMNM | → 0 | Neutral | 79.033.784 $ | -23.395.379 $ | -22,8 % | 1 | 102.429.163 $ | +46.589.056 $ | +83,4 % | 1 | 55.840.107 $ | +11.492.285 $ | +25,9 % | 1 |
| Sionna Therapeutics, Inc. | SION | → 0 | Schwach | 99.344.223 $ | -2.601.931 $ | -2,6 % | 1 | 101.946.154 $ | +29.067.292 $ | +39,9 % | 1 | 72.878.862 $ | +29.885.041 $ | +69,5 % | 1 |
| Upstream Bio, Inc. | UPB | → 0 | Neutral | 22.137.327 $ | -44.643.609 $ | -66,9 % | 1 | 66.780.936 $ | +20.513.923 $ | +44,3 % | 1 | 46.267.013 $ | +19.259.474 $ | +71,3 % | 1 |
| Compass Therapeutics, Inc. | CMPX | → 0 | Neutral | 41.199.314 $ | -623.052 $ | -1,5 % | 1 | 41.822.366 $ | +14.563.841 $ | +53,4 % | 1 | 27.258.525 $ | +7.009.335 $ | +34,6 % | 1 |
| BridgeBio Oncology Therapeutics, Inc. | BBOT | → 0 | Neutral | 23.511.167 $ | -9.378.197 $ | -28,5 % | 1 | 32.889.364 $ | +2.469.329 $ | +8,1 % | 1 | 30.420.035 $ | +30.420.035 $ | 1 | |
| Camp4 Therapeutics Corp | CAMP | → 0 | Neutral | 9.661.957 $ | -8.947.650 $ | -48,1 % | 1 | 18.609.607 $ | +7.252.201 $ | +63,9 % | 1 | 11.357.406 $ | +5.867.993 $ | +106,9 % | 1 |
| 351.507.330 $ | -155.274.923 $ | -30,9 % | 7 | 506.782.253 $ | +179.258.135 $ | +51,9 % | 7 | 327.524.118 $ | +150.988.764 $ | +72,9 % | 7 | ||||